Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Figure 3 SNHG5 knockdown suppresses 5-fluorouracil resistance in 5-fluorouracil-resistant colorectal cancer cells.
A: The expression of SNHG5 was assessed in 5-fluorouracil (5-Fu)-resistant colorectal cancer (CRC) cells (LOVO/5-Fu, HT-29/5-Fu) which were transfected with SNHG5-short hairpin RNA and negative control lentivirus; B and C: The viability of LOVO/5-Fu and HT-29/5-Fu cells treated with 5-Fu at different concentrations was evaluated, and the IC50 of 5-Fu-resistant CRC cells was calculated; D: The apoptosis rate of stable cells treated with 5-Fu was analyzed using annexin-V fluorescein 5-isothiocyanate/propidium iodide staining assays (left) and quantified (right); E: Western blot analysis was performed to assess the expression of markers of apoptosis (Bax and Bcl-2), with β-actin as an internal control (left), and densitometric analysis of Western blot signals is shown (right). bP < 0.01. cP < 0.001. shSNHG5: SNHG5-short hairpin RNA; shNC: Negative control-short hairpin RNA; 5-Fu: 5-fluorouracil.
- Citation: Wang B, Zhou Q, Cheng CE, Gu YJ, Jiang TW, Qiu JM, Wei GN, Feng YD, Ren LH, Shi RH. Long noncoding RNA SNHG5 promotes 5-fluorouracil resistance in colorectal cancer by regulating miR-26b/p-glycoprotein axis. World J Gastrointest Oncol 2025; 17(5): 102417
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102417.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102417